CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Effects of Teriparatide Treatment and Discontinuation in Postmenopausal Women and Eugonadal Men with Osteoporosis
Authors
Adami
Benjamin Z. Leder
+33Â more
Bikle
Black
Black
Brabant
Canalis
Cosman
Cosman
Ensrud
Finkelstein
Finkelstein
Hang W. Lee
Jason J. Wyland
Joborn
Joel S. Finkelstein
Kaufman
Khosla
Khosla
Lauretani
Leder
Lee
Lindsay
Miller
Neer
O'Connor
Orwoll
Prince
Riggs
Robert M. Neer
Rosenthal
Sherri-Ann M. Burnett-Bowie
Tsai
Venken
Zaidi
Publication date
Publisher
The Endocrine Society
Doi
Cite
View
on
PubMed
Abstract
Context: In postmenopausal women, bone mineral density (BMD) declines after teriparatide therapy is stopped. The pattern of BMD loss after teriparatide therapy is stopped in men is less clear
Similar works
Full text
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
Last time updated on 02/01/2020